AISA Pharma Announces Positive Data Safety Monitoring Board Review of First Phase 2 Data of Profervia® to treat Raynaud’s Disease in Scleroderma Patients
Company to Move Forward with Key U.S. Regulatory Applications – Investigational New Drug and Orphan…